Pfizer Forecasts $ 36 Billion Annual Revenue From Covid-19 Vaccine — World Today News

  • Post category:News
  • Post comments:0 Comments
Pfizer Forecasts $ 36 Billion Annual Revenue From Covid-19 Vaccine - featured image

First modification: 02/11/2021 – 16:00 US drugmaker Pfizer on Tuesday raised its annual revenue estimates for the Covid vaccine Comirnaty, which it develops with German biotech BioNTech, citing strong demand outside the United States. Now the company expects to sell the vaccine this year for $ 36 billion, up from a previous forecast of $…

Pfizer Forecasts $ 36 Billion Annual Revenue From Covid-19 Vaccine — World Today News
Advertisements

Leave a Reply